Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices

End-of-life decision making is a troublesome ethical dilemma. These decisions should be made in trustful patient–doctor relationships. We aimed to propose a balanced approach when discussing this complex issue. We categorized the research into four approaches and suggest that a multidisciplinary app...

Full description

Bibliographic Details
Main Authors: Akira Akabayashi, Eisuke Nakazawa, Hiroyasu Ino
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Clinics and Practice
Subjects:
Online Access:https://www.mdpi.com/2039-7283/12/5/79
_version_ 1797474130973425664
author Akira Akabayashi
Eisuke Nakazawa
Hiroyasu Ino
author_facet Akira Akabayashi
Eisuke Nakazawa
Hiroyasu Ino
author_sort Akira Akabayashi
collection DOAJ
description End-of-life decision making is a troublesome ethical dilemma. These decisions should be made in trustful patient–doctor relationships. We aimed to propose a balanced approach when discussing this complex issue. We categorized the research into four approaches and suggest that a multidisciplinary approach may be appropriate. We also analyzed the pitfalls of the multidisciplinary approach. Our conclusion is two-fold. First, discussions in this field should be based on real-world practice. If this is not the case, the proposal may be armchair theory, which is not effective in a clinical setting. Second, interdisciplinary researchers should not stick to their position too firmly and should listen to others. Otherwise, proposals made will be paternalistic or philosophically biased. Therefore, when philosophical collaboration is applied to the topic of clinical bioethics, it is necessary to thoroughly examine different positions and carry out careful discussions with consideration for medical care settings. Researchers must also understand what is needed for a trustful patient–doctor relationship. By making such efforts, clinical bioethics will contribute to the wellbeing of patients.
first_indexed 2024-03-09T20:26:45Z
format Article
id doaj.art-f5eb4c58b5084826b41c88c7ddcc042e
institution Directory Open Access Journal
issn 2039-7283
language English
last_indexed 2024-03-09T20:26:45Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Clinics and Practice
spelling doaj.art-f5eb4c58b5084826b41c88c7ddcc042e2023-11-23T23:35:01ZengMDPI AGClinics and Practice2039-72832022-09-0112576076510.3390/clinpract12050079Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World PracticesAkira Akabayashi0Eisuke Nakazawa1Hiroyasu Ino2Department of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Biomedical Ethics, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanEnd-of-life decision making is a troublesome ethical dilemma. These decisions should be made in trustful patient–doctor relationships. We aimed to propose a balanced approach when discussing this complex issue. We categorized the research into four approaches and suggest that a multidisciplinary approach may be appropriate. We also analyzed the pitfalls of the multidisciplinary approach. Our conclusion is two-fold. First, discussions in this field should be based on real-world practice. If this is not the case, the proposal may be armchair theory, which is not effective in a clinical setting. Second, interdisciplinary researchers should not stick to their position too firmly and should listen to others. Otherwise, proposals made will be paternalistic or philosophically biased. Therefore, when philosophical collaboration is applied to the topic of clinical bioethics, it is necessary to thoroughly examine different positions and carry out careful discussions with consideration for medical care settings. Researchers must also understand what is needed for a trustful patient–doctor relationship. By making such efforts, clinical bioethics will contribute to the wellbeing of patients.https://www.mdpi.com/2039-7283/12/5/79decision-making capacitypatient–doctor relationshipclinical ethicsend of lifetrust
spellingShingle Akira Akabayashi
Eisuke Nakazawa
Hiroyasu Ino
Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices
Clinics and Practice
decision-making capacity
patient–doctor relationship
clinical ethics
end of life
trust
title Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices
title_full Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices
title_fullStr Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices
title_full_unstemmed Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices
title_short Decision-Making Capacity to Refuse Treatment at the End of Life: The Need for Recognizing Real-World Practices
title_sort decision making capacity to refuse treatment at the end of life the need for recognizing real world practices
topic decision-making capacity
patient–doctor relationship
clinical ethics
end of life
trust
url https://www.mdpi.com/2039-7283/12/5/79
work_keys_str_mv AT akiraakabayashi decisionmakingcapacitytorefusetreatmentattheendoflifetheneedforrecognizingrealworldpractices
AT eisukenakazawa decisionmakingcapacitytorefusetreatmentattheendoflifetheneedforrecognizingrealworldpractices
AT hiroyasuino decisionmakingcapacitytorefusetreatmentattheendoflifetheneedforrecognizingrealworldpractices